BRCA1 and neoplasm: In August 2018, the province of Ontario implemented clinical reflex tumor BRCA1/2 testing as a funded, standard‐of‐care service for all cases of newly diagnosed HGSC and previously diagnosed cases with negative germline BRCA1/2 testing.